Furthermore, we combined the results of WGCNA and DEGs, validated by clinical samples, and found that BCL11A, GLT8D1, and NCBP2 were the key hub genes highly associated with the MLL status in childhood MLL-r ALL patients. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.